Casdin Capital’s Structure Therapeutics GPCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $25.4M | Buy |
1,225,000
+525,000
| +75% | +$10.9M | 2.31% | 10 |
|
|
2025
Q1 | $12.1M | Hold |
700,000
| – | – | 0.99% | 18 |
|
|
2024
Q4 | $19M | Hold |
700,000
| – | – | 1.26% | 18 |
|
|
2024
Q3 | $30.7M | Hold |
700,000
| – | – | 2.05% | 12 |
|
|
2024
Q2 | $27.5M | Sell |
700,000
-416,867
| -37% | -$16.4M | 2.1% | 13 |
|
|
2024
Q1 | $47.9M | Buy |
1,116,867
+25,000
| +2% | +$1.07M | 3.56% | 9 |
|
|
2023
Q4 | $44.5M | Sell |
1,091,867
-166,299
| -13% | -$6.78M | 4.37% | 5 |
|
|
2023
Q3 | $62M | Buy |
1,258,166
+261,149
| +26% | +$12.9M | 6.86% | 4 |
|
|
2023
Q2 | $41.4M | Buy |
997,017
+320,000
| +47% | +$13.3M | 3.62% | 10 |
|
|
2023
Q1 | $16.1M | Buy |
+677,017
| New | +$16.1M | 1.33% | 23 |
|